|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/22 | |
| A61P 9/10 | |||
| A61P 9/12 |
| (11) | Patento numeris | 3256151 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16749691.8 |
| Europos patento paraiškos padavimo data | 2016-02-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-12-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/017102 |
| Data | 2016-02-09 |
| (87) | Numeris | WO 2016/130518 |
| Data | 2016-08-18 |
| (30) | Numeris | Data | Šalis |
| 201562113943 P | 2015-02-09 | US | |
| 201562145770 P | 2015-04-10 | US | |
| 201562150679 P | 2015-04-21 | US |
| (72) |
GEORGOPOULOS, Lynne, US
ARNOLD, Susan, US
BALLANCE, David James, US
|
| (73) |
Phasebio Pharmaceuticals, Inc.,
One Great Valley Parkway Suite 30, Malvern, Pennsylvania 19355,
US
|
| (54) | METHODS AND COMPOSITIONS FOR TREATING MUSCLE DISEASE AND DISORDERS |
| METHODS AND COMPOSITIONS FOR TREATING MUSCLE DISEASE AND DISORDERS |